The robotic biobanking systems market size has grown rapidly in recent years. It will grow from $2.3 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to growth in clinical research samples, biobank infrastructure investments, demand for sample traceability, limitations of manual storage, early automation adoption.
The robotic biobanking systems market size is expected to see rapid growth in the next few years. It will grow to $4.57 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to precision medicine growth, expansion of genomic studies, large scale clinical trials, digital biorepository management, AI enabled sample analytics. Major trends in the forecast period include automated sample storage and retrieval, enhanced sample traceability, high throughput biobank operations, reduced human handling errors, long term sample integrity management.
The growing volume of biological sample collections is expected to drive the expansion of the robotic biobanking systems market in the coming years. Biological sample collections involve systematically gathering and preserving materials such as blood, tissue, saliva, or other biospecimens, along with related data, for use in biomedical research, diagnostics, and therapeutic development. The increase in biological sample collections is largely fueled by the rising demand for precision medicine, as modern healthcare increasingly relies on large, well-characterized biospecimen repositories to support genomic research, biomarker discovery, and the creation of personalized treatment strategies. Robotic biobanking systems facilitate this growth by automating the handling, storage, and retrieval of samples, ensuring accuracy, efficiency, and scalability as sample volumes rise. For example, in July 2025, UK Biobank Limited, a UK-based large-scale biomedical database, announced plans to relocate over 11 million samples to its new Manchester headquarters in 2026. The facility will house four next-generation automated freezers capable of storing up to 20 million samples, with robotic systems retrieving approximately 1 million samples annually - four times faster than the current capacity. As a result, the rising volume of biological sample collections is propelling the growth of the robotic biobanking systems market.
Leading companies in the robotic biobanking systems market are focusing on strategic collaborations to enhance technological capabilities, expand service accessibility, and accelerate the adoption of automation in advanced biobanking workflows. Such collaborations involve partnerships between technology providers, healthcare institutions, and research organizations to leverage complementary strengths, foster innovation, improve operational efficiency, and increase market reach. For instance, in October 2025, Abu Dhabi Biobank, a UAE-based hybrid cord blood bank, partnered with NMC Healthcare, a UAE healthcare provider, to expand access to private and public cord blood banking services across major hospitals in the region. The collaboration supports personalized healthcare and stem cell research through the integration of robotic and automated biobanking systems. The initiative aims to establish one of the region’s largest cord blood repositories, supported by advanced robotic handling and long-term automated storage technologies, while promoting awareness of the benefits of cord blood preservation and encouraging contributions to future biomedical research and regenerative medicine.
In July 2025, Hamilton Company, a Switzerland-based provider of liquid handling, process analytics, robotics, and automated storage solutions, acquired UK Robotics and Trisonic Discovery for an undisclosed sum. This acquisition enables Hamilton to strengthen its laboratory automation capabilities by integrating advanced scheduling software, system integration expertise, and precision acoustic dispensing technologies to deliver fully automated, scalable research workflows. UK Robotics and Trisonic Discovery are UK-based providers specializing in robotic biobanking systems.
Major companies operating in the robotic biobanking systems market are Thermo Fisher Scientific Inc., Beckman Coulter Inc., Tecan Group Ltd., Hamilton Company, Azenta Life Sciences, Haier Biomedical Co., BICO, SPT Labtech Ltd., HighRes Biosolutions Inc., LiCONiC AG, ASKION GmbH, Angelantoni Life Science Srl, SciRobotics Ltd., MGI Tech Co. Ltd., B Medical Systems S.a.r.l, Sakura Finetek Japan Co. Ltd., Panasonic Healthcare Co. Ltd., Brooks Automation Inc., Labcyte Inc., RTS Life Science Ltd., Kriosystem Life Sciences S.r.l.
North America was the largest region in the robotic biobanking systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic biobanking systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic biobanking systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of robotic arms, cryogenic systems, and automated storage components used in biobanking systems. North America and Europe face higher import costs due to reliance on Asia-Pacific suppliers. These tariffs have slowed some capital investments but are encouraging regional manufacturing, system standardization, and cost-optimized robotic platforms.
The robotic biobanking systems market research report is one of a series of new reports that provides robotic biobanking systems market statistics, including robotic biobanking systems industry global market size, regional shares, competitors with a robotic biobanking systems market share, detailed robotic biobanking systems market segments, market trends and opportunities, and any further data you may need to thrive in the robotic biobanking systems industry. This robotic biobanking systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Robotic biobanking systems are automated, computer-controlled platforms designed to manage, process, and store biological specimens with high precision and minimal human intervention. These systems integrate robotics, artificial intelligence, and data management technologies to ensure accuracy, traceability, and long-term sample integrity within biorepositories. They are primarily used in biomedical research, clinical studies, and pharmaceutical development to streamline specimen handling and improve operational efficiency.
The key product types in robotic biobanking systems include automated sample storage systems, automated sample retrieval systems, automated sample processing systems, and others. Automated sample storage systems are technologically advanced, fully automated units designed to securely store, organize, and retrieve biological specimens with high precision and efficiency under controlled environmental conditions. Sample types include blood, tissue, cells, DNA/RNA, and others, stored across cryogenic, ambient, and refrigerated environments. These systems are used in applications such as clinical research, pharmaceutical and biotech research, academic and research institutions, and biobank management, serving end users including hospitals, research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
The robotic biobanking systems market consists of sales of automated tube decapping systems, automated capping and recapping systems, robotic plate handling systems, automated liquid handling systems, and sample identification and scanning modules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The robotic biobanking systems market size is expected to see rapid growth in the next few years. It will grow to $4.57 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to precision medicine growth, expansion of genomic studies, large scale clinical trials, digital biorepository management, AI enabled sample analytics. Major trends in the forecast period include automated sample storage and retrieval, enhanced sample traceability, high throughput biobank operations, reduced human handling errors, long term sample integrity management.
The growing volume of biological sample collections is expected to drive the expansion of the robotic biobanking systems market in the coming years. Biological sample collections involve systematically gathering and preserving materials such as blood, tissue, saliva, or other biospecimens, along with related data, for use in biomedical research, diagnostics, and therapeutic development. The increase in biological sample collections is largely fueled by the rising demand for precision medicine, as modern healthcare increasingly relies on large, well-characterized biospecimen repositories to support genomic research, biomarker discovery, and the creation of personalized treatment strategies. Robotic biobanking systems facilitate this growth by automating the handling, storage, and retrieval of samples, ensuring accuracy, efficiency, and scalability as sample volumes rise. For example, in July 2025, UK Biobank Limited, a UK-based large-scale biomedical database, announced plans to relocate over 11 million samples to its new Manchester headquarters in 2026. The facility will house four next-generation automated freezers capable of storing up to 20 million samples, with robotic systems retrieving approximately 1 million samples annually - four times faster than the current capacity. As a result, the rising volume of biological sample collections is propelling the growth of the robotic biobanking systems market.
Leading companies in the robotic biobanking systems market are focusing on strategic collaborations to enhance technological capabilities, expand service accessibility, and accelerate the adoption of automation in advanced biobanking workflows. Such collaborations involve partnerships between technology providers, healthcare institutions, and research organizations to leverage complementary strengths, foster innovation, improve operational efficiency, and increase market reach. For instance, in October 2025, Abu Dhabi Biobank, a UAE-based hybrid cord blood bank, partnered with NMC Healthcare, a UAE healthcare provider, to expand access to private and public cord blood banking services across major hospitals in the region. The collaboration supports personalized healthcare and stem cell research through the integration of robotic and automated biobanking systems. The initiative aims to establish one of the region’s largest cord blood repositories, supported by advanced robotic handling and long-term automated storage technologies, while promoting awareness of the benefits of cord blood preservation and encouraging contributions to future biomedical research and regenerative medicine.
In July 2025, Hamilton Company, a Switzerland-based provider of liquid handling, process analytics, robotics, and automated storage solutions, acquired UK Robotics and Trisonic Discovery for an undisclosed sum. This acquisition enables Hamilton to strengthen its laboratory automation capabilities by integrating advanced scheduling software, system integration expertise, and precision acoustic dispensing technologies to deliver fully automated, scalable research workflows. UK Robotics and Trisonic Discovery are UK-based providers specializing in robotic biobanking systems.
Major companies operating in the robotic biobanking systems market are Thermo Fisher Scientific Inc., Beckman Coulter Inc., Tecan Group Ltd., Hamilton Company, Azenta Life Sciences, Haier Biomedical Co., BICO, SPT Labtech Ltd., HighRes Biosolutions Inc., LiCONiC AG, ASKION GmbH, Angelantoni Life Science Srl, SciRobotics Ltd., MGI Tech Co. Ltd., B Medical Systems S.a.r.l, Sakura Finetek Japan Co. Ltd., Panasonic Healthcare Co. Ltd., Brooks Automation Inc., Labcyte Inc., RTS Life Science Ltd., Kriosystem Life Sciences S.r.l.
North America was the largest region in the robotic biobanking systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic biobanking systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic biobanking systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of robotic arms, cryogenic systems, and automated storage components used in biobanking systems. North America and Europe face higher import costs due to reliance on Asia-Pacific suppliers. These tariffs have slowed some capital investments but are encouraging regional manufacturing, system standardization, and cost-optimized robotic platforms.
The robotic biobanking systems market research report is one of a series of new reports that provides robotic biobanking systems market statistics, including robotic biobanking systems industry global market size, regional shares, competitors with a robotic biobanking systems market share, detailed robotic biobanking systems market segments, market trends and opportunities, and any further data you may need to thrive in the robotic biobanking systems industry. This robotic biobanking systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Robotic biobanking systems are automated, computer-controlled platforms designed to manage, process, and store biological specimens with high precision and minimal human intervention. These systems integrate robotics, artificial intelligence, and data management technologies to ensure accuracy, traceability, and long-term sample integrity within biorepositories. They are primarily used in biomedical research, clinical studies, and pharmaceutical development to streamline specimen handling and improve operational efficiency.
The key product types in robotic biobanking systems include automated sample storage systems, automated sample retrieval systems, automated sample processing systems, and others. Automated sample storage systems are technologically advanced, fully automated units designed to securely store, organize, and retrieve biological specimens with high precision and efficiency under controlled environmental conditions. Sample types include blood, tissue, cells, DNA/RNA, and others, stored across cryogenic, ambient, and refrigerated environments. These systems are used in applications such as clinical research, pharmaceutical and biotech research, academic and research institutions, and biobank management, serving end users including hospitals, research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
The robotic biobanking systems market consists of sales of automated tube decapping systems, automated capping and recapping systems, robotic plate handling systems, automated liquid handling systems, and sample identification and scanning modules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Robotic Biobanking Systems Market Characteristics
3. Robotic Biobanking Systems Market Supply Chain Analysis
4. Global Robotic Biobanking Systems Market Trends and Strategies
5. Robotic Biobanking Systems Market Analysis of End Use Industries
7. Global Robotic Biobanking Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Robotic Biobanking Systems Total Addressable Market (TAM) Analysis for the Market
9. Robotic Biobanking Systems Market Segmentation
10. Robotic Biobanking Systems Market Regional and Country Analysis
11. Asia-Pacific Robotic Biobanking Systems Market
12. China Robotic Biobanking Systems Market
13. India Robotic Biobanking Systems Market
14. Japan Robotic Biobanking Systems Market
15. Australia Robotic Biobanking Systems Market
16. Indonesia Robotic Biobanking Systems Market
17. South Korea Robotic Biobanking Systems Market
18. Taiwan Robotic Biobanking Systems Market
19. South East Asia Robotic Biobanking Systems Market
20. Western Europe Robotic Biobanking Systems Market
21. UK Robotic Biobanking Systems Market
22. Germany Robotic Biobanking Systems Market
23. France Robotic Biobanking Systems Market
24. Italy Robotic Biobanking Systems Market
25. Spain Robotic Biobanking Systems Market
26. Eastern Europe Robotic Biobanking Systems Market
27. Russia Robotic Biobanking Systems Market
28. North America Robotic Biobanking Systems Market
29. USA Robotic Biobanking Systems Market
30. Canada Robotic Biobanking Systems Market
31. South America Robotic Biobanking Systems Market
32. Brazil Robotic Biobanking Systems Market
33. Middle East Robotic Biobanking Systems Market
34. Africa Robotic Biobanking Systems Market
36. Robotic Biobanking Systems Market Competitive Landscape and Company Profiles
37. Robotic Biobanking Systems Market Other Major and Innovative Companies
40. Robotic Biobanking Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Robotic Biobanking Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses robotic biobanking systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for robotic biobanking systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic biobanking systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Automated Sample Storage Systems; Automated Sample Retrieval Systems; Automated Sample Processing Systems2) By Sample Type: Blood; Tissue; Cells; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA)
3) By Storage Type: Cryogenic; Ambient; Refrigerated
4) By Application: Clinical Research; Pharmaceutical And Biotech Research; Academic And Research Institutes; Biobank Management
5) By End-User: Hospitals; Research Institutes; Pharma And Biotech; Contract Research Organizations (CROs)
Subsegments:
1) By Automated Sample Storage Systems: Modular Storage Units; High-Throughput Storage Systems; Compact Storage Systems; Integrated Storage And Tracking Platforms2) By Automated Sample Retrieval Systems: Barcode-Based Retrieval Systems; Robotic Arm Retrieval Systems; Automated Carousel Retrieval Systems; Vertical Lift Retrieval Systems
3) By Automated Sample Processing Systems: Automated Sample Aliquoting Systems; Automated Sample Sorting Systems; Automated Sample Labeling Systems; Automated Sample Tracking Systems
Companies Mentioned: Thermo Fisher Scientific Inc.; Beckman Coulter Inc.; Tecan Group Ltd.; Hamilton Company; Azenta Life Sciences; Haier Biomedical Co.; BICO; SPT Labtech Ltd.; HighRes Biosolutions Inc.; LiCONiC AG; ASKION GmbH; Angelantoni Life Science Srl; SciRobotics Ltd.; MGI Tech Co. Ltd.; B Medical Systems S.a.r.l; Sakura Finetek Japan Co. Ltd.; Panasonic Healthcare Co. Ltd.; Brooks Automation Inc.; Labcyte Inc.; RTS Life Science Ltd.; Kriosystem Life Sciences S.r.l.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Robotic Biobanking Systems market report include:- Thermo Fisher Scientific Inc.
- Beckman Coulter Inc.
- Tecan Group Ltd.
- Hamilton Company
- Azenta Life Sciences
- Haier Biomedical Co.
- BICO
- SPT Labtech Ltd.
- HighRes Biosolutions Inc.
- LiCONiC AG
- ASKION GmbH
- Angelantoni Life Science Srl
- SciRobotics Ltd.
- MGI Tech Co. Ltd.
- B Medical Systems S.a.r.l
- Sakura Finetek Japan Co. Ltd.
- Panasonic Healthcare Co. Ltd.
- Brooks Automation Inc.
- Labcyte Inc.
- RTS Life Science Ltd.
- Kriosystem Life Sciences S.r.l.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.65 Billion |
| Forecasted Market Value ( USD | $ 4.57 Billion |
| Compound Annual Growth Rate | 14.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
